A Ph 1B Study of the Anti-Cancer Stem Cell Agent Demcizumab (Dem) & Gemcitabine (Gem) +/- Paclitaxel Protein Bound Particles (Nab-Paclitaxel) in Pts with Pancreatic Cancer

  • Hidalgo M
  • Jameson M
  • Carrato A
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Hidalgo, M., Jameson, M., Carrato, A., Cooray, P., Parnis, F., Grimson, P., … Tebbutt, N. (2014). A Ph 1B Study of the Anti-Cancer Stem Cell Agent Demcizumab (Dem) & Gemcitabine (Gem) +/- Paclitaxel Protein Bound Particles (Nab-Paclitaxel) in Pts with Pancreatic Cancer. Annals of Oncology, 25, iv210. https://doi.org/10.1093/annonc/mdu334.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free